特刊：胶质母细胞瘤辅助治疗的主要挑战
Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma.
作者信息
Halatsch Marc-Eric
机构信息
Department of Neurosurgery, Cantonal Hospital of Winterthur, CH-8400 Winterthur, Switzerland.
出版信息
Biomedicines. 2023 Jul 3;11(7):1881. doi: 10.3390/biomedicines11071881.
Abstract
Despite advances in local treatments, such as supramaximal resection (even in eloquent locations [...].
摘要
尽管在局部治疗方面取得了进展，如超最大限度切除（即使在功能区位置[...]。
相似文献
1
Special Issue: Principal Challenges in the Adjuvant Treatment of Glioblastoma.
Biomedicines. 2023 Jul 3;11(7):1881. doi: 10.3390/biomedicines11071881.
2
Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
J Neurooncol. 2020 Jul;148(3):501-508. doi: 10.1007/s11060-020-03541-5. Epub 2020 Jul 5.
3
Risk factors for glioblastoma therapy associated complications.
Clin Neurol Neurosurg. 2015 Jul;134:55-9. doi: 10.1016/j.clineuro.2015.01.006. Epub 2015 Jan 9.
4
Supramaximal resection: A systematic review of its safety, efficacy and feasibility in glioblastoma.
J Clin Neurosci. 2020 Feb;72:328-334. doi: 10.1016/j.jocn.2019.12.021. Epub 2019 Dec 18.
5
T2 Fluid-Attenuated Inversion Recovery Resection for Glioblastoma Involving Eloquent Brain Areas Facilitated Through Awake Craniotomy and Clinical Outcome.
World Neurosurg. 2020 Mar;135:e738-e747. doi: 10.1016/j.wneu.2019.12.130. Epub 2019 Dec 30.
6
Awake craniotomy versus craniotomy under general anesthesia without surgery adjuncts for supratentorial glioblastoma in eloquent areas: a retrospective matched case-control study.
Acta Neurochir (Wien). 2019 Feb;161(2):307-315. doi: 10.1007/s00701-018-03788-y. Epub 2019 Jan 7.
7
Effect of awake craniotomy in glioblastoma in eloquent areas (GLIOMAP): a propensity score-matched analysis of an international, multicentre, cohort study.
Lancet Oncol. 2022 Jun;23(6):802-817. doi: 10.1016/S1470-2045(22)00213-3. Epub 2022 May 12.
8
Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.
Neurosurg Focus. 2014 Dec;37(6):E16. doi: 10.3171/2014.10.FOCUS14524.
9
The Merits of Awake Craniotomy for Glioblastoma in the Left Hemispheric Eloquent Area: One Institution Experience.
Clin Neurol Neurosurg. 2021 Jan;200:106343. doi: 10.1016/j.clineuro.2020.106343. Epub 2020 Nov 2.
10
What surgical approach for left-sided eloquent glioblastoma: biopsy, resection under general anesthesia or awake craniotomy?
J Neurooncol. 2022 Nov;160(2):445-454. doi: 10.1007/s11060-022-04163-9. Epub 2022 Nov 3.
本文引用的文献
1
EGFR, the Lazarus target for precision oncology in glioblastoma.
Neuro Oncol. 2022 Dec 1;24(12):2035-2062. doi: 10.1093/neuonc/noac204.
2
Radical supramaximal resection for newly diagnosed left-sided eloquent glioblastoma: safety and improved survival over gross-total resection.
J Neurosurg. 2022 May 27;138(1):62-69. doi: 10.3171/2022.3.JNS212399. Print 2023 Jan 1.
3
Emerging therapies for glioblastoma: current state and future directions.
J Exp Clin Cancer Res. 2022 Apr 15;41(1):142. doi: 10.1186/s13046-022-02349-7.
4
In Vitro and Clinical Compassionate Use Experiences with the Drug-Repurposing Approach CUSP9v3 in Glioblastoma.
Pharmaceuticals (Basel). 2021 Nov 29;14(12):1241. doi: 10.3390/ph14121241.
5
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
Neurooncol Adv. 2021 Jun 24;3(1):vdab075. doi: 10.1093/noajnl/vdab075. eCollection 2021 Jan-Dec.
6
Impact of F-FET PET/MRI on Clinical Management of Brain Tumor Patients.
J Nucl Med. 2022 Apr;63(4):522-527. doi: 10.2967/jnumed.121.262051. Epub 2021 Aug 5.
7
Haloperidol Induced Cell Cycle Arrest and Apoptosis in Glioblastoma Cells.
Biomedicines. 2020 Dec 11;8(12):595. doi: 10.3390/biomedicines8120595.
8
Considering the Experimental use of Temozolomide in Glioblastoma Research.
Biomedicines. 2020 Jun 4;8(6):151. doi: 10.3390/biomedicines8060151.
9
Anti-epidermal growth factor receptor therapy for glioblastoma in adults.
Cochrane Database Syst Rev. 2020 May 12;5(5):CD013238. doi: 10.1002/14651858.CD013238.pub2.
10
Comment in Response to "Temozolomide in Glioblastoma Therapy: Role of Apoptosis, Senescence and Autophagy etc. by B. Kaina".
Biomedicines. 2020 Apr 20;8(4):93. doi: 10.3390/biomedicines8040093.
Zotero 插件